GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Burzynski Research Institute BZYR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Burzynski Research Institute

Its shares trade under the ticker BZYR. It has been listed since 15 October 2001.

Burzynski Research Institute, Inc. engages in research, production, marketing, promotion and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids under the trade name Antineoplastons. The company is headquartered in Houston, Texas. The company went IPO on 2001-10-15. Antineoplastons are found in the bodily fluids of humans and food. The firm is reviewing data of its Phase II clinical trials of Antineoplastons relating to the treatment of various cancers. All Phase II clinical trials are for the treatment of a range of cancers using only a combination of Antineoplastons A10 and AS2-1. Most of the trials involve the use of intravenous formulations of Antineoplastons, however, a few trials use oral formulations. The firm is also conducting laboratory research involving new generations of Antineoplastons, A10 and AS2-1.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
15 Oct 2001
Employees
2
Head office
12000 RICHMOND AVE, HOUSTON, TX, 77082
Incorporated in
DE
Classification
In Vitro & In Vivo Diagnostic Substances
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Dr. Stanislaw BurzynskiChairman of the Board, President, since 1984
  • Dr. Tomasz JanickiVice President - Clinical Trials
  • Mr. Patryk GoscianskiTreasurer, Secretary
  • Dr. Gregory BurzynskiDirector
  • Ms. Monika Szopa - PaszkowiakDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Burzynski Research Institute Inc possesses several strengths:

Weaknesses

  • Although Burzynski Research Institute Inc has many strengths, it also faces some weaknesses:

Opportunities

  • Burzynski Research Institute Inc can leverage the following opportunities:

Threats

  • Despite its strengths, Burzynski Research Institute Inc faces several threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.